Clinical trialNCT03928184CompletedPhase 3Interventional

Patient-Reported and Radiographic Outcomes in Evaluating Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis

SponsorBiosplice Therapeutics, Inc.Enrollment501Knee Osteoarthritis

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Yusuf Yazici, M.D.
Biosplice Therapeutics, Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

99 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Birmingham, Alabama, United States
Research Site
Birmingham, Alabama, United States
Research Site
Birmingham, Alabama, United States
Research Site
Peoria, Arizona, United States
Research Site
Phoenix, Arizona, United States
Research Site
Tucson, Arizona, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Anaheim, California, United States
Research Site
Garden Grove, California, United States
Research Site
Norco, California, United States
Research Site
Pomona, California, United States
Research Site
San Diego, California, United States
Research Site
San Marcos, California, United States
Research Site
Spring Valley, California, United States
Research Site
Westminster, California, United States
Research Site
Boulder, Colorado, United States
Research Site
Colorado Springs, Colorado, United States
Research Site
Denver, Colorado, United States
Research Site
Waterbury, Connecticut, United States
Research Site
Clearwater, Florida, United States
Research Site
Coral Gables, Florida, United States
Research Site
Hialeah, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Miami Lakes, Florida, United States
Research Site
Orlando, Florida, United States
Research Site
Oviedo, Florida, United States
Research Site
Port Orange, Florida, United States
Research Site
Sunrise, Florida, United States
Research Site
West Palm Beach, Florida, United States
Research Site
Winter Haven, Florida, United States
Research Site #1
Winter Park, Florida, United States
Research Site #2
Winter Park, Florida, United States
Research Site
Marietta, Georgia, United States
Research Site
Newnan, Georgia, United States
Research Site
Stockbridge, Georgia, United States
Research Site
Woodstock, Georgia, United States
Research Site
Boise, Idaho, United States
Research Site
Meridian, Idaho, United States
Research Site
Bloomington, Illinois, United States
Research Site
Gurnee, Illinois, United States

59 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 17 May 2019
Primary completion: 20 Aug 2021
Completion: 20 Aug 2021
Last update posted: 13 Feb 2026
Registered enrollment: 501
Registry id: NCT03928184

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.